Physician profile
Matthew C Messina
NPI 1861151961
$2,156.92
in general payments reported to CMS, 2019-2025
16 companies · $969 in 2025
The $969 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $331 · 2023: $423 · 2024: $434 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.94 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $558.51 | 2025 | Rybrevant, Carvykti, Erleada |
| Antares Pharma, INC. | $379.46 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $288.49 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $263.18 | 2022-2024 | Aveed, Xiaflex, Edex |
| Astellas Pharma US INC | $172.94 | 2022-2025 | Xtandi |
| Novartis Pharmaceuticals Corporation | $106.49 | 2022-2025 | |
| Halozyme INC | $73.71 | 2023 | |
| Pfizer INC. | $69.57 | 2023-2024 | |
| Tolmar, INC. | $66.14 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $45.14 | 2022 | |
| Acerus Pharmaceuticals Corporation | $27.11 | 2022 | |
| Blue Earth Diagnostics | $25.63 | 2024 | |
| Abbvie INC. | $23.54 | 2022 | |
| Hologic Sales and Service, LLC | $20.15 | 2022 | |
| Olympus America INC. | $18.61 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $18.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Messina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.